Skip to main content

Assessment of ARIA Sufficiency: Rystiggo (rozanolixizumab-noli)

    Basic Details
    Approval Date
    Monday, June 26, 2023
    Original Posting Date
    Health Outcome(s)
    adverse pregnancy and fetal outcomes